Àü¹ÝÀûÀÎ °£Áú ȯÀÚ¿¡¼ ÅäÇǶó¸ÞÀÌÆ®¿Í ¶ó¸ðÆ®¸®ÁøÀÌ ³ú Æ÷µµ´ç´ë»ç¿¡ ¹ÌÄ¡´Â ¿µÇâ
The Effect ofTopiramate and Lamotrigine on Cerebral Glucose Metabolism in Idiopathic Generalized Epilepsy Patients
ÁÖÀº¿¬, Å¿켮, ÇѼ±Á¤, ÇѼ®±Ù, À̼ºÀÍ, ¼´ë¿ø, ÀÌ°æÇÑ, È«½ÂºÀ,
¼Ò¼Ó »ó¼¼Á¤º¸
ÁÖÀº¿¬ ( Joo Eun-Yeon )
¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ »ï¼º¼¿ïº´¿ø ½Å°æ°úÇб³½Ç
Å¿켮 ( Tae Woo-Suk )
¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ »ï¼º¼¿ïº´¿ø ½Å°æ°úÇб³½Ç
ÇѼ±Á¤ ( Han Sun-Jung )
¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ »ï¼º¼¿ïº´¿ø ½Å°æ°úÇб³½Ç
ÇѼ®±Ù ( )
¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ »ï¼º¼¿ïº´¿ø ´ëÀå¼¾ÅÍ ¿Ü°úÇб³½Ç
À̼ºÀÍ ( Lee Sung-Ik )
¿ø±¤´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ°úÇб³½Ç
¼´ë¿ø ( Seo Dae-Won )
¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ »ï¼º¼¿ïº´¿ø ½Å°æ°ú
ÀÌ°æÇÑ ( Lee Kyung-Han )
¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ »ï¼º¼¿ïº´¿ø ÇÙÀÇÇаú
È«½ÂºÀ ( Hong Seung-Bong )
¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ »ï¼º¼¿ïº´¿ø ½Å°æ°úÇб³½Ç
KMID : 0877220050090020129
Abstract
Background: To investigate the effects of topiramate (TPM) or lamotrigine (LTG) on cerebral glucose metabolism, we performed 18F-fluorodeoxy glucose positron emission tomography (FDG-PET) before and after medication in patients with drug naive idiopathic generalized epilepsy.
Methods: Thiry-three patients with newly diagnosed as idiopathic generalized epilepsy (IGE) or IGE without antiepileptic drugs after diagnosis were included. Pre- and post-antiepileptic drug FDG-PET were performed (before and after TPM or LTG administration) in 33 subjects treated with TPM or LTG who had been seizure free for at least 8 weeks. Sixteen of patients received TPM (M/F=8/8, aged 29.2+/-12.3 years) and 17 LTG (M/F=8/9, 26.8+/-9.3 years). For statistical paramateric (SPM) analysis, all PET images were spatially normalized to the standard PET template and then smoothed using a 12-mm full width at half-maximum Gaussian kernel. The paired t-test was used to compare pre- and post-medication FDG-PET images.
Results: SPM analysis of post- and pre-medication FDG-PETs showed TPM reduced glucose metabolism markedly in the thalamus, corpus callosum, and white matters, whereas LTG decreased glucose metabolism in cortico-striato-entorhinal areas with a false discovery rate corrected p<0.05. No brain region showed post-medication hypermetabolism in either group.
Conclusion: Our study demonstrates that both TPM and LTG affect the cerebral glucose metabolism in drug naive idiopathic generalized epilepsy patients.
Å°¿öµå
Epilepsy;Topiramate;lamotrigine;Cerebral metabolism;FDG-PET;Statistical parametric mapping
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸